Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks

Objectives To examine the performance of screening for hypertensive disorders in pregnancy by a combination of the maternal factor‐derived a‐priori risk with the uterine artery (UtA) pulsatility index (PI) and to determine whether it is best in such screening to use the mean PI of the two arteries,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ultrasound in obstetrics & gynecology 2009-08, Vol.34 (2), p.142-148
Hauptverfasser: Poon, L. C. Y., Staboulidou, I., Maiz, N., Plasencia, W., Nicolaides, K. H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 148
container_issue 2
container_start_page 142
container_title Ultrasound in obstetrics & gynecology
container_volume 34
creator Poon, L. C. Y.
Staboulidou, I.
Maiz, N.
Plasencia, W.
Nicolaides, K. H.
description Objectives To examine the performance of screening for hypertensive disorders in pregnancy by a combination of the maternal factor‐derived a‐priori risk with the uterine artery (UtA) pulsatility index (PI) and to determine whether it is best in such screening to use the mean PI of the two arteries, the highest PI or the lowest PI. Methods This was a prospective screening study for pre‐eclampsia (PE) requiring delivery before 34 weeks (early PE), late PE and gestational hypertension (GH) in women attending their routine first hospital visit in pregnancy at 11 + 0 to 13 + 6 weeks of gestation. Maternal history was recorded and color flow Doppler imaging was used to measure the left and right UtA‐PI. The performance of screening for PE and GH by a combination of the maternal factor‐derived a‐priori risks determined in a previous study and the UtA‐PI was assessed. Results There were 8061 (96.4%) cases unaffected by PE or GH, 37 (0.4%) that developed early PE, 128 (1.5%) with late PE and 140 (1.7%) with GH. The lowest, mean and highest UtA‐PI were significantly higher in early PE and late PE than in the controls (P < 0.0001) and in early PE than late PE (P < 0.0001). The lowest UtA‐PI was higher in GH than in controls (P = 0.014). The best performance in screening was provided by the lowest PI. The detection rate of early PE at a 10% false‐positive rate increased from 47% in screening by maternal factors alone to 81% in screening by maternal factors and the lowest UtA‐PI. The respective detection rates for late PE increased from 41% to 45% and those for GH increased from 31% to 35%. Conclusions The patient‐specific risk for PE and GH can be derived by combining the disease‐specific maternal factor‐derived a‐priori risk with the measurement of the lowest UtA‐PI in a multivariate regression model. Copyright © 2009 ISUOG. Published by John Wiley & Sons, Ltd.
doi_str_mv 10.1002/uog.6452
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733574689</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733574689</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4172-4447935c9615ff88dba9fd609902d917803ba086f83d61a504cf7602797fd8f53</originalsourceid><addsrcrecordid>eNp90LtOxDAQBVALgWB5SHwBcoOgCYwfsWM6tDwlJBooqCJvMl4ZskmwN6B0_AN_yJeQhRVUUE1z5l7pErLL4IgB8OOumR4pmfIVMmJSmQQ0pKtkBEZBopXhG2QzxkcAUFKodbLBjJLSSD0iD1d9i2GOdfQvSEsfm1BiiNTXtA04rW1d9Cc0FgGx9vWUTnrazTH4Gqkd3kJPz5q2rTBQO6eMfby9M0FfEZ_iNllztoq4s7xb5P7i_G58ldzcXl6PT2-SQjLNEymlNiItjGKpc1lWTqxxpQJjgJeG6QzExEKmXCZKxWwKsnBaAddGuzJzqdgiB9-5bWieO4zzfOZjgVVla2y6mGshUi1VZgZ5-K9kwIZUwQ380iI0MQZ0eRv8zIZ-QPli8nyYPF9MPtC9ZWo3mWH5C5cbD2B_CWwsbOXCsKmPP46zjEuhF53Jt3v1FfZ_Fub3t5dfxZ-aoJaj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017973290</pqid></control><display><type>article</type><title>Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Poon, L. C. Y. ; Staboulidou, I. ; Maiz, N. ; Plasencia, W. ; Nicolaides, K. H.</creator><creatorcontrib>Poon, L. C. Y. ; Staboulidou, I. ; Maiz, N. ; Plasencia, W. ; Nicolaides, K. H.</creatorcontrib><description>Objectives To examine the performance of screening for hypertensive disorders in pregnancy by a combination of the maternal factor‐derived a‐priori risk with the uterine artery (UtA) pulsatility index (PI) and to determine whether it is best in such screening to use the mean PI of the two arteries, the highest PI or the lowest PI. Methods This was a prospective screening study for pre‐eclampsia (PE) requiring delivery before 34 weeks (early PE), late PE and gestational hypertension (GH) in women attending their routine first hospital visit in pregnancy at 11 + 0 to 13 + 6 weeks of gestation. Maternal history was recorded and color flow Doppler imaging was used to measure the left and right UtA‐PI. The performance of screening for PE and GH by a combination of the maternal factor‐derived a‐priori risks determined in a previous study and the UtA‐PI was assessed. Results There were 8061 (96.4%) cases unaffected by PE or GH, 37 (0.4%) that developed early PE, 128 (1.5%) with late PE and 140 (1.7%) with GH. The lowest, mean and highest UtA‐PI were significantly higher in early PE and late PE than in the controls (P &lt; 0.0001) and in early PE than late PE (P &lt; 0.0001). The lowest UtA‐PI was higher in GH than in controls (P = 0.014). The best performance in screening was provided by the lowest PI. The detection rate of early PE at a 10% false‐positive rate increased from 47% in screening by maternal factors alone to 81% in screening by maternal factors and the lowest UtA‐PI. The respective detection rates for late PE increased from 41% to 45% and those for GH increased from 31% to 35%. Conclusions The patient‐specific risk for PE and GH can be derived by combining the disease‐specific maternal factor‐derived a‐priori risk with the measurement of the lowest UtA‐PI in a multivariate regression model. Copyright © 2009 ISUOG. Published by John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0960-7692</identifier><identifier>ISSN: 1469-0705</identifier><identifier>EISSN: 1469-0705</identifier><identifier>DOI: 10.1002/uog.6452</identifier><identifier>PMID: 19644947</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Arterial hypertension. Arterial hypotension ; Arteries ; Arteries - diagnostic imaging ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cardiovascular system ; Color ; Diseases of mother, fetus and pregnancy ; Doppler effect ; Epidemiologic Methods ; Female ; Gestation ; gestational hypertension ; Growth hormone ; Gynecology ; Gynecology. Andrology. Obstetrics ; Hospitals ; Humans ; Hypertension ; Hypertension, Pregnancy-Induced - diagnostic imaging ; Hypertension, Pregnancy-Induced - epidemiology ; Hypertension, Pregnancy-Induced - physiopathology ; imaging ; Investigative techniques, diagnostic techniques (general aspects) ; Medical sciences ; Obstetrics ; Pre-eclampsia ; Pregnancy ; Pregnancy Trimester, First ; Pregnancy-Associated Plasma Protein-A - analysis ; Pregnancy. Fetus. Placenta ; Regression analysis ; screening ; Ultrasonic investigative techniques ; Ultrasonography, Doppler, Color - standards ; Ultrasonography, Doppler, Color - utilization ; Ultrasonography, Prenatal - standards ; Ultrasonography, Prenatal - utilization ; Ultrasound ; uterine artery Doppler ; Uterus ; Uterus - blood supply</subject><ispartof>Ultrasound in obstetrics &amp; gynecology, 2009-08, Vol.34 (2), p.142-148</ispartof><rights>Copyright © 2009 ISUOG. Published by John Wiley &amp; Sons, Ltd.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4172-4447935c9615ff88dba9fd609902d917803ba086f83d61a504cf7602797fd8f53</citedby><cites>FETCH-LOGICAL-c4172-4447935c9615ff88dba9fd609902d917803ba086f83d61a504cf7602797fd8f53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fuog.6452$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fuog.6452$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21824370$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19644947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poon, L. C. Y.</creatorcontrib><creatorcontrib>Staboulidou, I.</creatorcontrib><creatorcontrib>Maiz, N.</creatorcontrib><creatorcontrib>Plasencia, W.</creatorcontrib><creatorcontrib>Nicolaides, K. H.</creatorcontrib><title>Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks</title><title>Ultrasound in obstetrics &amp; gynecology</title><addtitle>Ultrasound Obstet Gynecol</addtitle><description>Objectives To examine the performance of screening for hypertensive disorders in pregnancy by a combination of the maternal factor‐derived a‐priori risk with the uterine artery (UtA) pulsatility index (PI) and to determine whether it is best in such screening to use the mean PI of the two arteries, the highest PI or the lowest PI. Methods This was a prospective screening study for pre‐eclampsia (PE) requiring delivery before 34 weeks (early PE), late PE and gestational hypertension (GH) in women attending their routine first hospital visit in pregnancy at 11 + 0 to 13 + 6 weeks of gestation. Maternal history was recorded and color flow Doppler imaging was used to measure the left and right UtA‐PI. The performance of screening for PE and GH by a combination of the maternal factor‐derived a‐priori risks determined in a previous study and the UtA‐PI was assessed. Results There were 8061 (96.4%) cases unaffected by PE or GH, 37 (0.4%) that developed early PE, 128 (1.5%) with late PE and 140 (1.7%) with GH. The lowest, mean and highest UtA‐PI were significantly higher in early PE and late PE than in the controls (P &lt; 0.0001) and in early PE than late PE (P &lt; 0.0001). The lowest UtA‐PI was higher in GH than in controls (P = 0.014). The best performance in screening was provided by the lowest PI. The detection rate of early PE at a 10% false‐positive rate increased from 47% in screening by maternal factors alone to 81% in screening by maternal factors and the lowest UtA‐PI. The respective detection rates for late PE increased from 41% to 45% and those for GH increased from 31% to 35%. Conclusions The patient‐specific risk for PE and GH can be derived by combining the disease‐specific maternal factor‐derived a‐priori risk with the measurement of the lowest UtA‐PI in a multivariate regression model. Copyright © 2009 ISUOG. Published by John Wiley &amp; Sons, Ltd.</description><subject>Arterial hypertension. Arterial hypotension</subject><subject>Arteries</subject><subject>Arteries - diagnostic imaging</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular system</subject><subject>Color</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Doppler effect</subject><subject>Epidemiologic Methods</subject><subject>Female</subject><subject>Gestation</subject><subject>gestational hypertension</subject><subject>Growth hormone</subject><subject>Gynecology</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension, Pregnancy-Induced - diagnostic imaging</subject><subject>Hypertension, Pregnancy-Induced - epidemiology</subject><subject>Hypertension, Pregnancy-Induced - physiopathology</subject><subject>imaging</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Medical sciences</subject><subject>Obstetrics</subject><subject>Pre-eclampsia</subject><subject>Pregnancy</subject><subject>Pregnancy Trimester, First</subject><subject>Pregnancy-Associated Plasma Protein-A - analysis</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Regression analysis</subject><subject>screening</subject><subject>Ultrasonic investigative techniques</subject><subject>Ultrasonography, Doppler, Color - standards</subject><subject>Ultrasonography, Doppler, Color - utilization</subject><subject>Ultrasonography, Prenatal - standards</subject><subject>Ultrasonography, Prenatal - utilization</subject><subject>Ultrasound</subject><subject>uterine artery Doppler</subject><subject>Uterus</subject><subject>Uterus - blood supply</subject><issn>0960-7692</issn><issn>1469-0705</issn><issn>1469-0705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90LtOxDAQBVALgWB5SHwBcoOgCYwfsWM6tDwlJBooqCJvMl4ZskmwN6B0_AN_yJeQhRVUUE1z5l7pErLL4IgB8OOumR4pmfIVMmJSmQQ0pKtkBEZBopXhG2QzxkcAUFKodbLBjJLSSD0iD1d9i2GOdfQvSEsfm1BiiNTXtA04rW1d9Cc0FgGx9vWUTnrazTH4Gqkd3kJPz5q2rTBQO6eMfby9M0FfEZ_iNllztoq4s7xb5P7i_G58ldzcXl6PT2-SQjLNEymlNiItjGKpc1lWTqxxpQJjgJeG6QzExEKmXCZKxWwKsnBaAddGuzJzqdgiB9-5bWieO4zzfOZjgVVla2y6mGshUi1VZgZ5-K9kwIZUwQ380iI0MQZ0eRv8zIZ-QPli8nyYPF9MPtC9ZWo3mWH5C5cbD2B_CWwsbOXCsKmPP46zjEuhF53Jt3v1FfZ_Fub3t5dfxZ-aoJaj</recordid><startdate>200908</startdate><enddate>200908</enddate><creator>Poon, L. C. Y.</creator><creator>Staboulidou, I.</creator><creator>Maiz, N.</creator><creator>Plasencia, W.</creator><creator>Nicolaides, K. H.</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200908</creationdate><title>Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks</title><author>Poon, L. C. Y. ; Staboulidou, I. ; Maiz, N. ; Plasencia, W. ; Nicolaides, K. H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4172-4447935c9615ff88dba9fd609902d917803ba086f83d61a504cf7602797fd8f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Arterial hypertension. Arterial hypotension</topic><topic>Arteries</topic><topic>Arteries - diagnostic imaging</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular system</topic><topic>Color</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Doppler effect</topic><topic>Epidemiologic Methods</topic><topic>Female</topic><topic>Gestation</topic><topic>gestational hypertension</topic><topic>Growth hormone</topic><topic>Gynecology</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension, Pregnancy-Induced - diagnostic imaging</topic><topic>Hypertension, Pregnancy-Induced - epidemiology</topic><topic>Hypertension, Pregnancy-Induced - physiopathology</topic><topic>imaging</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Medical sciences</topic><topic>Obstetrics</topic><topic>Pre-eclampsia</topic><topic>Pregnancy</topic><topic>Pregnancy Trimester, First</topic><topic>Pregnancy-Associated Plasma Protein-A - analysis</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Regression analysis</topic><topic>screening</topic><topic>Ultrasonic investigative techniques</topic><topic>Ultrasonography, Doppler, Color - standards</topic><topic>Ultrasonography, Doppler, Color - utilization</topic><topic>Ultrasonography, Prenatal - standards</topic><topic>Ultrasonography, Prenatal - utilization</topic><topic>Ultrasound</topic><topic>uterine artery Doppler</topic><topic>Uterus</topic><topic>Uterus - blood supply</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poon, L. C. Y.</creatorcontrib><creatorcontrib>Staboulidou, I.</creatorcontrib><creatorcontrib>Maiz, N.</creatorcontrib><creatorcontrib>Plasencia, W.</creatorcontrib><creatorcontrib>Nicolaides, K. H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Ultrasound in obstetrics &amp; gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poon, L. C. Y.</au><au>Staboulidou, I.</au><au>Maiz, N.</au><au>Plasencia, W.</au><au>Nicolaides, K. H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks</atitle><jtitle>Ultrasound in obstetrics &amp; gynecology</jtitle><addtitle>Ultrasound Obstet Gynecol</addtitle><date>2009-08</date><risdate>2009</risdate><volume>34</volume><issue>2</issue><spage>142</spage><epage>148</epage><pages>142-148</pages><issn>0960-7692</issn><issn>1469-0705</issn><eissn>1469-0705</eissn><abstract>Objectives To examine the performance of screening for hypertensive disorders in pregnancy by a combination of the maternal factor‐derived a‐priori risk with the uterine artery (UtA) pulsatility index (PI) and to determine whether it is best in such screening to use the mean PI of the two arteries, the highest PI or the lowest PI. Methods This was a prospective screening study for pre‐eclampsia (PE) requiring delivery before 34 weeks (early PE), late PE and gestational hypertension (GH) in women attending their routine first hospital visit in pregnancy at 11 + 0 to 13 + 6 weeks of gestation. Maternal history was recorded and color flow Doppler imaging was used to measure the left and right UtA‐PI. The performance of screening for PE and GH by a combination of the maternal factor‐derived a‐priori risks determined in a previous study and the UtA‐PI was assessed. Results There were 8061 (96.4%) cases unaffected by PE or GH, 37 (0.4%) that developed early PE, 128 (1.5%) with late PE and 140 (1.7%) with GH. The lowest, mean and highest UtA‐PI were significantly higher in early PE and late PE than in the controls (P &lt; 0.0001) and in early PE than late PE (P &lt; 0.0001). The lowest UtA‐PI was higher in GH than in controls (P = 0.014). The best performance in screening was provided by the lowest PI. The detection rate of early PE at a 10% false‐positive rate increased from 47% in screening by maternal factors alone to 81% in screening by maternal factors and the lowest UtA‐PI. The respective detection rates for late PE increased from 41% to 45% and those for GH increased from 31% to 35%. Conclusions The patient‐specific risk for PE and GH can be derived by combining the disease‐specific maternal factor‐derived a‐priori risk with the measurement of the lowest UtA‐PI in a multivariate regression model. Copyright © 2009 ISUOG. Published by John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>19644947</pmid><doi>10.1002/uog.6452</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-7692
ispartof Ultrasound in obstetrics & gynecology, 2009-08, Vol.34 (2), p.142-148
issn 0960-7692
1469-0705
1469-0705
language eng
recordid cdi_proquest_miscellaneous_733574689
source Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Arterial hypertension. Arterial hypotension
Arteries
Arteries - diagnostic imaging
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cardiovascular system
Color
Diseases of mother, fetus and pregnancy
Doppler effect
Epidemiologic Methods
Female
Gestation
gestational hypertension
Growth hormone
Gynecology
Gynecology. Andrology. Obstetrics
Hospitals
Humans
Hypertension
Hypertension, Pregnancy-Induced - diagnostic imaging
Hypertension, Pregnancy-Induced - epidemiology
Hypertension, Pregnancy-Induced - physiopathology
imaging
Investigative techniques, diagnostic techniques (general aspects)
Medical sciences
Obstetrics
Pre-eclampsia
Pregnancy
Pregnancy Trimester, First
Pregnancy-Associated Plasma Protein-A - analysis
Pregnancy. Fetus. Placenta
Regression analysis
screening
Ultrasonic investigative techniques
Ultrasonography, Doppler, Color - standards
Ultrasonography, Doppler, Color - utilization
Ultrasonography, Prenatal - standards
Ultrasonography, Prenatal - utilization
Ultrasound
uterine artery Doppler
Uterus
Uterus - blood supply
title Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T23%3A56%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypertensive%20disorders%20in%20pregnancy:%20screening%20by%20uterine%20artery%20Doppler%20at%2011%E2%80%9313%20weeks&rft.jtitle=Ultrasound%20in%20obstetrics%20&%20gynecology&rft.au=Poon,%20L.%20C.%20Y.&rft.date=2009-08&rft.volume=34&rft.issue=2&rft.spage=142&rft.epage=148&rft.pages=142-148&rft.issn=0960-7692&rft.eissn=1469-0705&rft_id=info:doi/10.1002/uog.6452&rft_dat=%3Cproquest_cross%3E733574689%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017973290&rft_id=info:pmid/19644947&rfr_iscdi=true